Actively Recruiting

Phase 2
Age: 18Years - 100Years
All Genders
NCT05764538

DAOIB for the Treatment of Brain Fog

Led by Chang Gung Memorial Hospital · Updated on 2026-03-19

40

Participants Needed

1

Research Sites

170 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a 24-week open trial. We will enroll long-COVID patients with cognitive impairments. All patients will receive DAOIB for 24 weeks. We will assess the patients every 8 weeks during the treatment period (weeks 0, 8, 16, and 24). We hypothesize that DAOIB treatment will be beneficial in improving the cognitive function, mood symptoms, global functioning and quality of life in long-COVID patients with cognitive impairments.

CONDITIONS

Official Title

DAOIB for the Treatment of Brain Fog

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Post-COVID-19 condition defined by WHO with symptoms present at three months after SARS-CoV-2 infection lasting at least 2 months, including COVID-induced cognitive impairments
  • Physically healthy with all laboratory assessments (urine/blood routine, biochemical tests, and electrocardiograph) within normal limits
  • Sufficient education to communicate effectively and able to complete study assessments
Not Eligible

You will not qualify if you...

  • History of significant cerebrovascular disease
  • Hachinski Ischemic Score greater than 4
  • Major neurological, psychiatric, or medical conditions other than long COVID-induced cognitive impairments
  • Current use of memantine (an NMDAR partial antagonist)
  • Substance (including alcohol) abuse or dependence
  • Presence of delusion, hallucination, or delirium symptoms
  • Severe visual or hearing loss
  • Inability to follow the study protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan, 886

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

DAOIB for the Treatment of Brain Fog | DecenTrialz